Literature DB >> 3129777

Tonsillar distribution of IgA and IgG immunocytes and production of IgA subclasses and J chain in tonsillitis vary with the presence or absence of IgA nephropathy.

J Nagy1, P Brandtzaeg.   

Abstract

At the onset or in the course of IgA nephropathy (IgA NP), upper respiratory tract infections and tonsillitis are often followed by periods of gross haematuria. In a search for possible abnormalities in the tonsillar IgA- and IgG-cell system, the palatine tonsils from seven patients with IgA NP and eight controls, all 15 suffering from chronic recurrent tonsillitis, were subjected to an immunohistochemical study. Compared with the controls, tonsils of NP patients contained a significantly (P less than 0.001) increased proportion of IgA-producing cells (49.6% versus 35.7%). There was also an increase (P less than 0.001) in the ratio of IgA polymer- (J-chain-positive) to monomer-producing cells in NP tonsils compared with controls (35.0% versus 18.8%). Although the tonsillar IgA cells were generally producing mainly IgA1, this subclass was even more predominant in NP tonsils (P less than 0.03). These results are compatible with the hypothesis that in some patients with IgA NP, the polymeric IgA1 deposited in the mesangium may be of tonsillar origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129777     DOI: 10.1111/j.1365-3083.1988.tb02362.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  H Nozawa; M Takahara; T Yoshizaki; T Goto; N Bandoh; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

2.  Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA.

Authors:  S J Harper; A C Allen; J H Pringle; J Feehally
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

3.  Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients.

Authors:  Tibor Kovács; Tibor Vas; Csaba P Kövesdy; Péter Degrell; Györgyi Nagy; Zsuzsanna Rékási; István Wittmann; Judit Nagy
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

4.  Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells.

Authors:  C Kusakari; M Nose; T Takasaka; R Yuasa; M Kato; K Miyazono; T Fujita; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; A van der Ark; P S Hiemstra; J Radl; L A van Es
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

6.  Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA.

Authors:  S J Harper; A C Allen; M C Béné; J H Pringle; G Faure; I Lauder; J Feehally
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

Review 7.  Pathogenesis of idiopathic IgA nephropathy.

Authors:  D G Williams
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

8.  Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

Authors:  A W van den Wall Bake; W E Beyer; J H Evers-Schouten; J Hermans; M R Daha; N Masurel; L A van Es
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 9.  Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome.

Authors:  Yasuaki Harabuchi; Miki Takahara
Journal:  Immun Inflamm Dis       Date:  2019-04-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.